17 C
New York
Wednesday, September 27, 2023

Medtronic plc (NYSE: MDT): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Medtronic plc (MDT) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.20, or -0.24%, to $82.60. The Medtronic plc has recorded 172,331 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Medtronic Foundation: 3 Ways To Transform Corporate Volunteering.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

MDT belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $82.80 and fluctuated between $83.64 as its day high and $82.11 as its day low. The current market capitalization of Medtronic plc is $110.42B. A total of 5.79 million shares were traded on the day, compared to an average of 4.81M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, MDT has seen 21 BUY and 14 SELL insider trades, representing the acquisition of 188,338 and the disposition of 56,896 shares. Over the last 12 months, there were 34 BUYs and 32 SELLs from insiders. Insiders purchased 226,367 shares during that period but sold 91,255.

In the most recent transaction, Smith Gregory L sold 10,000 shares of MDT for 83.84 per share on Aug 23. After the transaction, the EVP Global Ops & Supply Chain now owns 46,723 company shares. In a previous transaction on Aug 14, Wall Brett A. sold 1,000 shares at 83.38 per share. MDT shares that EVP & Pres Neuroscience owns now total 33,573.

Among the insiders who sold shares, Marinaro Michael disposed of 1,352 shares on Aug 04 at a per-share price of $84.11. This resulted in the EVP & President, Surgical OU holding 28,930 shares of MDT after the transaction. In another insider transaction, Wall Brett A. sold 2,000 shares at $87.97 per share on Jul 14. Company shares held by the EVP & Pres Neuroscience now total 23,948.


Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Medtronic plc pays an annual dividend of $2.76, resulting in a dividend yield of 3.33%, and it has a price to earnings (P/E) ratio of 30.47. MDT’s most recent ex-dividend date was 9/21/2023 when it declared a $0.69 quarterly dividend that was paid in cash on 10/13/2023. Previously, the company paid the dividend on 7/14/2023 with an ex-dividend date of 6/22/2023. The MDT stock dividend was $0.69 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for MDT in the last 3 months, the mean price target is $92.92 with high estimates of $104.00 and low estimates of $80.00. In terms of 52-week highs and lows, MDT has a high of $92.02 and a low of $75.76.

As of this writing, MDT has an earnings estimate of $1.18 per share for the current quarter. EPS was calculated based on a consensus of 27 estimates, with a high estimate of $1.2 per share and a lower estimate of $1.16. The company reported an EPS of $1.57 in the last quarter, which was 0.60% higher than expectations of $1.56.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. MDT’s latest balance sheet shows that the firm has $10.57B in Cash & Short Term Investments as of fiscal 2022. There were $24.11B in debt and $12.39B in liabilities at the time. Its Book Value Per Share was $38.47, while its Total Shareholder’s Equity was $52.72B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MDT is Buy with a score of 3.78.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles